Arkolith/Insider Trading/PHAT/Form 4

Curran Terrie

President and Chief Executive, DirectorPhathom Pharmaceuticals, Inc. (PHAT) · full profile →Form 4 · filed Jan 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$126K
Net Open-Market Flow
-$126K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2025Sell(S)19K$6.59$126K360K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-008348) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML